Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients

Journal of Clinical Oncology

Volumn 21, Issue 18, 2003, Pages 3447-3453

  Herida, Magid ^a   Mary Krause, Murielle ^a   Kaphan, Régis ^a   Cadranel, Jacques ^a   Poizot Martin, Isabelle ^a   Rabaud, Christian ^a   Plaisance, Nathalie ^a   Tissot Dupont, Hervé ^a   Boue, François ^a   Lang, Jean Marie ^a   Costagliola, Dominique ^a  

^a HÔPITAL TENON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGE DISTRIBUTION; ARTICLE; CANCER INCIDENCE; CONTROLLED STUDY; DATA BASE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; SEX DIFFERENCE; ADOLESCENT; ADULT; AGED; COMPARATIVE STUDY; FRANCE; INCIDENCE; MIDDLE AGED; NEOPLASM; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; FRANCE; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES;

EID: 0142026064     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.01.096     Document Type: Article

References (47)

1. Ancelle-Park E: Expanded European AIDS definition. Lancet 341:441, 1993
2. Hajjar M, Lacoste D, Brossard G, et al: Non-acquired immune deficiency syndrome-defining malignancies in a hospital-based cohort of human immunodeficiency virus-infected patients: Bordeaux, France, 1985-1991. J Natl Cancer Inst 84:1593-1595, 1992
3. Biggar RJ, Curtis RE, Coté TR, et al: Risk of other cancers following Kaposi's sarcoma: Relation to acquired immunodeficiency syndrome. Am J Epidemiol 139:362-368, 1994
4. Serraino D, Pezzotti P, Dorrucci M, et al: Cancer incidence in a cohort of human immunodeficiency virus seroconverters. Cancer 79:1004-1008, 1997
5. Goedert JJ, Coté TR, Virgo P, et al: Spectrum of AIDS-associated malignant disorders. Lancet 351:1833-1839, 1998
6. Franceschi S, Dal Maso L, Arniabi S, et al: Risk of cancer other than Kaposi's sarcoma and non-Hodgkin's lymphoma in persons with AIDS in Italy. Br J Cancer 78:966-970, 1998
7. Grulich AE, Wan X, Law MG, et al: Risk of cancer in patients with AIDS. AIDS 13:839-843, 1999
8. Serraino D, Boschini A, Carrieri P, et al: Cancer risk among men with, or at risk of, HIV infection in southern Europe. AIDS 14:553-559, 2000
9. Frisch M, Biggar RJ, Engels EA, et al: Association of cancer with AIDS-related immunosuppression in adults. JAMA 285:1736-1745, 2001
10. Gallagher B, Wang Z, Schymura MJ, et al: Cancer incidence in New York State acquired immunodeficiency syndrome patients. Am J Epidemiol 154:544-556, 2001
11. Grulich AE, Li Y, McDonald A, et al: Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis. AIDS 16:1155-1161, 2002
12. Biggar RJ: AIDS-related cancers in the era of highly active antiretroviral therapy. Oncology 15:439-448, 2001
13. Curtis RE, Rowlings PA, Deeg HJ, et al: Solid cancers after bone marrow transplantation. N Engl J Med 336:897-904, 1997
14. Vacher-Coponat H, Dussol B, Berland Y: Affections néoplasiques et transplantations d'organes. Rev Med Interne 20:992-1003, 1999
15. Gastaut J, Poizot-Martin I, Collesto R: Les affections malignes au cours de l'infection par le VIH. Paris, France, Ellipses ED, 2001
16. Blattner W: Human retroviruses: their role in cancer. Proc Assoc Am Physicians 111:563-572, 1999
17. Mack KD, Wei R, Herndier B, et al: HIV insertional cis-activation of the protooncogene c-fes in AIDS associated lymphomagenesis. J Acquir Immune Defic Syndr Hum Retrovirol 14:A44, 1997 (abstr 114)
18. Marsh JW, Herndier B, Tsuzuki A, et al: Cytokine expression in large cell lymphoma associated with acquired immunodeficiency syndrome. J Interferon Cytokine Res 15:261-268, 1995
19. Ott M, Emiliani S, Van Lint C, et al: Immune hyperactivation of HIV-1-infected T cells mediated by Tat and the CD28 pathway. Science 275:1481-1485, 1997
20. Palella FJ Jr, Delaney KM, Moorman AC, et al: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 338:853-860, 1998
21. Besson C, Goubar A, Gabarre J, et al: Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood 98:2339-2344, 2001
22. International Collaboration on HIV and Cancer: Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 92:1823-1830, 2000
23. Tassié JM, Gasnault J, Bentata M, et al: Survival improvement of AIDS-related progressive multifocal leukoencephalopathy in the era of protease inhibitors. AIDS 13:1881-1887, 1999
24. World Health Organization: Manuel de la classification statistique internationale des maladies, traumatismes et causes de décès (Révision 1995). Geneva, Switzerland, World Health Organization, 1977
25. World Health Organization: Classification statistique internationale des maladies et des problèmes de santé convexes. Dixième révision. Geneva, Switzerland, World Health Organization, 1993
26. Réseau FRANCIM: Le cancer en France: Incidence et mortalité. Paris, France, La documentation française, 1998
27. Breslow N, Day N: Statistical Methods in Cancer Research: Vol II. The Design and Analysis of Cohort Studies. Lyon, France, International Agency for Research on Cancer, 1987
28. Mbulaiteye SM, Biggar RJ, Goedert JJ, et al: Immune deficiency and risk for malignancy among persons with AIDS. JAIDS 32:527-533, 2003
29. Hessol NA, Katz MH, Liu JY, et al: Increased incidence of Hodgkin disease in homosexual men with HIV infection. Ann Intern Med 117:309-311, 1992
30. Petruckevitch A, Del Amo J, Phillips AN, et al: Risk of cancer in patients with HIV disease. Int J STD AIDS 10:38-42, 1999
31. Reynolds P, Saunders LD, Layefsky ME, et al: The spectrum of acquired immunodeficiency syndrome (AIDS)-associated malignancies in San Francisco 1980-1987. Am J Epidemiol 137:19-30, 1993
32. Selik RM, Rabkin CS: Cancer death rates associated with human immunodeficiency virus infection in the United States. J Natl Cancer Inst 90:1300-1302, 1998
33. Lyter DW, Bryant J, Thackeray R, et al: Incidence of human immunodeficiency virus-related and non-related malignancies in a large cohort of homosexual men. J Clin Oncol 13:2540-2546, 1995
34. Koblin BA, Hessol NA, Zauber AG, et al: Increased incidence of cancer among homosexual men, New York City and San Francisco, 1978-1990. Am J Epidemiol 144:916-923, 1996
35. Frisch M, Biggar RJ, Goedert JJ: Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 92:1500-1510, 2000
36. Tirelli U, Vaccher E, Spina M, et al: Hodgkin's disease: Clinical presentation and treatment. Cancer Treat Res 104:247-265, 2001
37. Jones JL, Hanson DL, Dworkin MS, et al: Effect of antiretroviral therapy on recent trends in selected cancers among HIV-infected persons. J Acquir Immune Defic Syndr 21:S11-S17, 1999 (suppl)
38. Savès M, Chêne G, Ducimetière P, et al: Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population. Clin Infect Dis 37:292-298, 2003
39. Parker MS, Leveno D, Campbell T, et al: AIDS-related bronchogenic carcinoma: Fact or Fiction? Chest 113:154-161, 1998
40. Vyzula R, Reemick S: Lung cancer in patients with HIV infection. Lung Cancer 15:325-339, 1996
41. Melbye M, Coté TR, Kessler L, et al: High incidence of anal cancer among AIDS patients. Lancet 343:636-639, 1994
42. Palefsky JM: Anal squamous intraepithelial lesions in human immunodeficiency virus-positive men and women. Semin Oncol 27:471-479, 2000
43. Baynham SA, Katner HP, Cleveland KB: Increased prevalence of renal cell carcinoma in patients with HIV infection. AIDS Patient Care STDs 11:161-165, 1997
44. IARC: Monographs on evaluation of carcinogenic risk to humans, some antiviral and antineoplastic drugs, and other pharmaceutical agents. International Agency for Research of Cancer scientific publication no. 76, Lyon, France, 2000, pp 35-127
45. Meng Q, Walker DM, Olivero OA, et al: Zidovudine-didanosine coexposure potentiates DNA incorporation of zidovudine and mutagenesis in human cells. Proc Natl Acad Sci U S A 97:12667-12671, 2000
46. Gaya SB, Rees AJ, Lechler RI, et al: Malignant disease in patients with long-term renal transplants. Transplantation 59:1705-1709, 1995
47. Ventura G, Tacconelli E, Tumbarello M, et al: Non-AIDS-defining neoplasms and HIV infection. Int J Mol Med 4:639-643, 1999